Search icon

Mitsubishi Tanabe Pharma America, Inc.

Company claim

Is this your business?

Get access!

Company Details

Name: Mitsubishi Tanabe Pharma America, Inc.
Jurisdiction: Rhode Island
Entity type: Foreign Corporation
Status: Activ
Date of Organization in Rhode Island: 12 May 2017 (8 years ago)
Identification Number: 001673741
Place of Formation: DELAWARE
Purpose: COMMERICALIZATION OF PHARMACEUTICALS
Historical names: MT Pharma America, Inc.
Principal Address: Google Maps Logo 525 WASHINGTON BLVD. SUITE 1100, JERSEY CITY, NJ, 07310, USA

Industry & Business Activity

NAICS

424210 Drugs and Druggists' Sundries Merchant Wholesalers

This industry comprises establishments primarily engaged in the merchant wholesale distribution of biological and medical products; botanical drugs and herbs; and pharmaceutical products intended for internal and/or external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau

Agent

Name Role Address
CT CORPORATION SYSTEM Agent 450 VETERANS MEMORIAL PARKWAY SUITE 7A, EAST PROVIDENCE, RI, 02914, USA

PRESIDENT

Name Role Address
YASUTOSHI KAWAKAMI PRESIDENT 525 WASHINGTON BLVD., SUITE 1100 JERSEY CITY, NJ 07310 USA

SECRETARY

Name Role Address
ELIZABETH KIM SECRETARY 525 WASHINGTON BLVD., SUITE 1100 JERSEY CITY, NJ 07310 USA

DIRECTOR

Name Role Address
YASUTOSHI KAWAKAMI DIRECTOR 525 WASHINGTON BLVD., SUITE 1100 JERSEY CITY, NJ 07310 USA

TREASURER

Name Role Address
SAM SHUM TREASURER 525 WASHINGTON BLVD., SUITE 1100 JERSEY CITY, NJ 07310 USA

Events

Type Date Old Value New Value
Name Change 2017-07-12 MT Pharma America, Inc. Mitsubishi Tanabe Pharma America, Inc.

Filings

Number Name File Date
202450786390 Annual Report 2024-04-11
202332652320 Annual Report 2023-04-10
202215153100 Annual Report 2022-04-19
202192029180 Annual Report 2021-02-19
202033544140 Annual Report 2020-02-01

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 21 Jun 2025

Sources: Rhode Island Department of State